Ausgabe 2/2020
Inhalt (10 Artikel)
Targeting Apoptosis in Acute Myeloid Leukemia: Current Status and Future Directions of BCL-2 Inhibition with Venetoclax and Beyond
Jun H. Choi, James M. Bogenberger, Raoul Tibes
Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer
Ramesh K. Ramanathan, Daniel D. Von Hoff, Ferry Eskens, George Blumenschein Jr., Donald Richards, Isabelle Genvresse, Susanne Reschke, Camille Granvil, Adam Skubala, Carol Peña, Klaus Mross
Chemotherapy Plus EGFR-TKI as First-Line Treatment Provides Better Survival for Advanced EGFR-Positive Lung Adenocarcinoma Patients: Updated Data and Exploratory In Vitro Study
Yuqing Lou, Jianlin Xu, Yanwei Zhang, Jun Lu, Tianqing Chu, Xueyan Zhang, Huimin Wang, Hua Zhong, Wei Zhang, Baohui Han
Use of Gefitinib in EGFR-Amplified Refractory Solid Tumors: An Open-Label, Single-Arm, Single-Center Prospective Pilot Study
Seonggyu Byeon, Jung Yong Hong, Jeeyun Lee, Do-Hyun Nam, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Seung Tae Kim
Sequential Treatment with Bevacizumab and Aflibercept for Metastatic Colorectal Cancer in Real-World Clinical Practice
Tomas Buchler, Igor Kiss, Jana Hornova, Ondrej Fiala, Marketa Wiesnerova, Michal Svoboda, Jiri Silar, Katerina Kopeckova, Alexandr Poprach, Jindrich Finek, Lubos Petruzelka, Bohuslav Melichar
Impact of Prior Ramucirumab Use on Treatment Outcomes of Checkpoint Inhibitors in Advanced Gastric Cancer Patients
Jinchul Kim, Seonggyu Byeon, Hyera Kim, Ja Hyun Yeo, Jung Yong Hong, Jeeyun Lee, Ho Yeong Lim, Won Ki Kang, Seung Tae Kim
Blood Myeloid-Derived Suppressor Cells Correlate with Neutrophil-to-Lymphocyte Ratio and Overall Survival in Metastatic Urothelial Carcinoma
Iris Y. Sheng, Claudia Marcela Diaz-Montero, Patricia Rayman, Wei Wei, James H. Finke, Jin S. Kim, Paul G. Pavicic Jr., Marcelo Lamenza, Donna Company, Andrew Stephenson, Steven Campbell, George Haber, Byron Lee, Omar Mian, Timothy D. Gilligan, Brian I. Rini, Jorge A. Garcia, Petros Grivas, Moshe C. Ornstein
Genomic Alterations and MYD88MUT Variant Mapping in Patients with Diffuse Large B-Cell Lymphoma and Response to Ibrutinib
Shiyu Jiang, Yan Qin, Lin Gui, Peng Liu, Hongxin Jiang, Biao Liu, Jianliang Yang, Sheng Yang, Xiaohui He, Shengyu Zhou, Xinhua Du, Yuting Yi, Jing Lin, Yuankai Shi
Oral Azacitidine and Cedazuridine Approximate Parenteral Azacitidine Efficacy in Murine Model
Haley E. Ramsey, Aram Oganesian, Agnieszka E. Gorska, Londa Fuller, Maria Arrate, Kelli Boyd, Harold Keer, Mohammad Azab, Michael R. Savona
Natural Killer Cells as a Potential Biomarker for Predicting Immunotherapy Efficacy in Patients with Non-Small Cell Lung Cancer
Yong-Hee Cho, Myeong Geun Choi, Dong Ha Kim, Yun Jung Choi, Seon Ye Kim, Ki Jung Sung, Jae Cheol Lee, Sang-Yeob Kim, Jin Kyung Rho, Chang-Min Choi